Gilead Sciences Inc
GILD:NASDAQ
| Last | Change / % Change | Dividend Yield | Volume | Avg Volume (10 day) |
| 56.36 | 0.00 0.00% | 0.00% | 0 | 14.2M |
Market data is delayed by at least 20 minutes.
5/16/2013 7:18 AM ET
| Market Comparison | P/E (TTM) | P/E (Forward 12 Months) | PEG | 1 Year EPS Growth Rate | 5 Year EPS Growth Rate |
| GILD Gilead Sciences Inc | 37.4 | 28.0 | 1.5 | -7.70% | 14.79% |
| Biotechnology & Drugs Industry | 53.0 | 16.1 | 3.3 | 11.30% | 8.20% |
| Healthcare Sector | 25.1 | 17.8 | 4.0 | -49.14% | 6.88% |
| S&P; 500 | 17.8 | 19.1 | 3.5 | -3.39% | 6.33% |
Earnings Summary
On 5/2/2013, GILD reported 1 quarter 2013 earnings of $0.48 per share. This result was in-line with the consensus of the 23 analysts following the company and beat last year's 1 quarter results by 5.49%.
The next earnings announcement is expected on 07/22/2013.GILD's PE ratio is among the highest of any stock in the Biotechnology & Drugs industry and signals that investors have high hopes for this company's future business prospects. However, during the past year, earnings growth has lagged its historical five year growth rate.